Delawareans Optimistic About Biden Cancer Moonshot Report - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

Delawareans Optimistic About Biden Cancer Moonshot Report

Posted: Updated:

DOVER, Del.- Delawareans say they're cautiously optimistic that stakeholders in the medical community will align to boost research into a cure for cancer and develop new, effective treatments for the disease following the release of Vice President Joe Biden's recommendations from his Cancer Moonshot Task Force.

Biden's report to President Barack Obama looked at various accomplishments the task force in the past year and outlined goals to help "dramatically accelerate efforts to prevent, diagnose, and treat cancer" and to achieve a "decade’s worth of progress in five years."

Biden's eldest son, Beau Biden, died last year from brain cancer at the age of 46. He was the former attorney general of Delaware and announced plans to seek the governor's office.

Currently in remission, Ruth Ann Piper of Dover said she exhausted nearly every available treatment option after her ovarian cancer returned. She said she hopes Biden's recommendations expand the range of treatments available to people with cancer.

"My worries are if it comes back. What do we go to now? Because there's no other drug, we have to do a combination of what I've already used," she said.

Theresa Hadley, a cancer survivor who owns the Pink Ribbon Boutique, a shop that sells apparel for women who are undergoing or had treatment for breast cancer, said she wants to see the data sharing and research goals proposed by the task force fulfilled because there's too many people whose lives are affected by cancer.

"I hope it really happens because a lot of times there's a lot of hype for a while and then it fades into the background and you don't see the end results being what we hoped for," she said.

You can read the vice president's report here.

Powered by Frankly

All content © Copyright 2000 - 2017 WBOC. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices